Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults

NCT00697242 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

362

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: Engerix™-B
BIOLOGICAL: Recombinant HBsAg with different concentrations of Aluminium Salts and/or MPL

Sponsor

GlaxoSmithKline